Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Conference Coverage

A person wearing a smart watch
Conference Coverage
Moving Beyond Video Visits for Telehealth in IBD
01/24/2022
Fernando Velayos, MD, and Sravanthi Parasa, MD, reviewed the methods currently used for telehealth and how to optimize and expand its implementation among patients with inflammatory bowel disease.
Fernando Velayos, MD, and Sravanthi Parasa, MD, reviewed the methods currently used for telehealth and how to optimize and expand its implementation among patients with inflammatory bowel disease.
Fernando Velayos, MD, and...
01/24/2022
Advances in Inflammatory Bowel Disease Network
Kelly Issokson, RD
Conference Coverage
Identifying and Assessing Malnutrition Among Patients with IBD
01/24/2022
Kelly Issokson, RD, discussed how to identify and assess inpatient malnutrition among patients with inflammatory bowel disease.
Kelly Issokson, RD, discussed how to identify and assess inpatient malnutrition among patients with inflammatory bowel disease.
Kelly Issokson, RD, discussed...
01/24/2022
Advances in Inflammatory Bowel Disease Network
Jean Ashburn
Conference Coverage
Involve the Surgeon Early for Patients With Acute Severe UC
01/22/2022
Early involvement of a surgeon who specializes in inflammatory bowel disease can optimize outcomes for hospitalized patients with ulcerative colitis, said Jean Ashburn, MD, at the Crohn's & Colitis Congress.
Early involvement of a surgeon who specializes in inflammatory bowel disease can optimize outcomes for hospitalized patients with ulcerative colitis, said Jean Ashburn, MD, at the Crohn's & Colitis Congress.
Early involvement of a surgeon...
01/22/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Frank Scott, MD
Conference Coverage
Treatment Algorithms for Biologic/Small Molecule Therapies in UC
01/22/2022
Frank Scott, MD, from the University of Colorado, discussed his study on simulating treatment algorithms to position therapies for moderate to severe ulcerative colitis at the 2022 Crohn’s and Colitis Congress.
Frank Scott, MD, from the University of Colorado, discussed his study on simulating treatment algorithms to position therapies for moderate to severe ulcerative colitis at the 2022 Crohn’s and Colitis Congress.
Frank Scott, MD, from the...
01/22/2022
Advances in Inflammatory Bowel Disease Network
Séverine Vermeire, MD, PhD
Conference Coverage
The Evolution of Clinical Trial Endpoints in IBD
01/21/2022
At Crohn's & Colitis Congress 2022, Dr Vermeire reviewed new endpoints for clinical trials and goals for inflammatory bowel disease management as they have evolved throughout the past 2 decades.
At Crohn's & Colitis Congress 2022, Dr Vermeire reviewed new endpoints for clinical trials and goals for inflammatory bowel disease management as they have evolved throughout the past 2 decades.
At Crohn's & Colitis Congress...
01/21/2022
Advances in Inflammatory Bowel Disease Network
Jean Fred
Conference Coverage
Jean-Frédéric Colombel, MD, on Advancing IBD Therapies
01/21/2022
In his keynote address to the Crohn’s & Colitis Congress, Dr Colombel urged better application of existing therapeutics and exploring the use of “rational combinations” of therapies to achieve better outcomes in inflammatory bowel disease.
In his keynote address to the Crohn’s & Colitis Congress, Dr Colombel urged better application of existing therapeutics and exploring the use of “rational combinations” of therapies to achieve better outcomes in inflammatory bowel disease.
In his keynote address to the...
01/21/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Robert Battat
Conference Coverage
Using Dual Therapy for Refractory Patients With IBD
01/21/2022
When conventional treatments fail, dual therapies with biologics and small molecules should be considered, Robert Battat, MD, said at the Crohn’s & Colitis Congress.
When conventional treatments fail, dual therapies with biologics and small molecules should be considered, Robert Battat, MD, said at the Crohn’s & Colitis Congress.
When conventional treatments...
01/21/2022
Advances in Inflammatory Bowel Disease Network
Ashwin Ananthakrishnan, MD, MPH
Conference Coverage
Ashwin Ananthakrishnan, MD, MPH, on the Clinical Year in Review
01/21/2022
Dr Ananthakrishnan, from Massachusetts General Hospital in Boston, discusses his presentation about the Clinical Year in Review from the 2022 Crohn's and Colitis Congress, on important research published and its implications for IBD care.
Dr Ananthakrishnan, from Massachusetts General Hospital in Boston, discusses his presentation about the Clinical Year in Review from the 2022 Crohn's and Colitis Congress, on important research published and its implications for IBD care.
Dr Ananthakrishnan, from...
01/21/2022
Advances in Inflammatory Bowel Disease Network
Edward Barnes, MD
Conference Coverage
Edward Barnes, MD, on Management of Ulcerative Colitis
01/20/2022
Dr Barnes reviews a case-based discussion at the Crohn's & Colitis Congress on managing ulcerative colitis.
Dr Barnes reviews a case-based discussion at the Crohn's & Colitis Congress on managing ulcerative colitis.
Dr Barnes reviews a case-based...
01/20/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Dolinger
Conference Coverage
Michael Dolinger, MD, on State of the Art Imaging in Pediatric IBD
01/20/2022
Dr Dolinger, from the Icahn School of Medicine at Mt Sinai in New York, discusses the use of advanced imaging such as intestinal ultrasound in managing inflammatory bowel disease among pediatric patients.
Dr Dolinger, from the Icahn School of Medicine at Mt Sinai in New York, discusses the use of advanced imaging such as intestinal ultrasound in managing inflammatory bowel disease among pediatric patients.
Dr Dolinger, from the Icahn...
01/20/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest News

News
Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis
11/12/2024
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do...
11/12/2024
Advances in Inflammatory Bowel Disease Network
News
Assessing Transmural Healing and Response in Patients with Crohn's Disease
11/11/2024
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score...
11/11/2024
Advances in Inflammatory Bowel Disease Network
News
MRE or IUS for Crohn’s Disease Imaging?
11/06/2024
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients...
11/06/2024
Advances in Inflammatory Bowel Disease Network
News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use